Authors: Boucard, M Pinguet, F Poujol, S Romieu, G Cupissol, D Astre, C Culine, S Bressolle, F

Citation: M. Boucard et al., Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer, EUR J CANC, 37(18), 2001, pp. 2357-2364

Authors: Culine, S Ychou, M Fabbro, M Romieu, G Cupissol, D

Citation: S. Culine et al., 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas ofunknown primary site, ANTICANC R, 21(2B), 2001, pp. 1455-1457

Authors: Culine, S Roch, I Pinguet, F Romieu, G Bressolle, F

Citation: S. Culine et al., Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines, INT J ONCOL, 14(5), 1999, pp. 999-1006

Authors: Culine, S Fabbro, M Ychou, M Romieu, G Cupissol, D Pujol, H

Citation: S. Culine et al., Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policy, ANN ONCOL, 10(5), 1999, pp. 569-575

Authors: Body, JJ Lortholary, A Romieu, G Vigneron, AM Ford, J

Citation: Jj. Body et al., A dose-finding study of zoledronate in hypercalcemic cancer patients, J BONE MIN, 14(9), 1999, pp. 1557-1561